Back

Clinical risk scores versus simple integrated clinical judgment in patients with suspected acute coronary syndromes

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: What defines risk in acute coronary syndromes Non-ST-Elevation Myocardial Infarction (NSTEMI) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Associate Professor Jasper Boeddinghaus

University Hospital Basel, Basel (Switzerland)

5 More presentations in this session

Presentation thumbnail
Bleeding risk in patients hospitalized for non-ST-segment elevation acute coronary syndromes in Switzerland: performance of the CRUSADE score
Doctor F. Wenzl (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Metabolic associated fatty liver disease increases risk of adverse events after acute coronary syndrome.
Doctor N. Chew (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Sex inequities in the performance of the GRACE 2.0 score in non-ST-segment elevation acute coronary syndromes: a multinational observational study in contemporary cohorts from four European countries
Doctor F. Wenzl (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Long-term non-cardiovascular morbidity risk remains elevated following myocardial infarction: a nationwide cohort study
Doctor D. Christensen (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
Association of ischemic and bleeding events with mortality in patients with a recent acute myocardial infarction
Ms M. Simonsson (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
What defines risk in acute coronary syndromes
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Does a high baseline high sensitivity cardiac troponin T allow for the early diagnosis of acute myocardial infarction?
thumbnail
Congress Presentation
The incremental value of non-necrosis biomarkers to risk stratification in acute chest pain, with MI excluded: the first prospective long term cohort study in the high sensitive troponin era
thumbnail
Congress Presentation
Validation of the GRACE 3.0 score and redefinition of the risk threshold for early invasive treatment in non-ST-segment elevation acute coronary syndromes: a modelling study from five countries

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources